Stay updated on ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.

Latest updates to the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA sitewide notice says NIH agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.7%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.7.0 was added as the latest revision to the record history, replacing the previous Revision: v3.6.6. This indicates an updated version of the page, without changes to the underlying study data or descriptions.SummaryDifference0.1%

- Check60 days agoChange DetectedAn additional revision entry, v3.6.6, has been added to the study record history, indicating an update to the record. The prior revision listed was v3.6.5.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision v3.6.5 has been added to the Study Record History and v3.6.4 has been removed. This updates the historical log to reflect the latest platform release on the page.SummaryDifference0.1%

- Check96 days agoChange DetectedThe study record history now shows a new current revision, v3.6.4, replacing the previous v3.6.3 in the version list.SummaryDifference0.1%

Stay in the know with updates to ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVANCE Study of Daratumumab Combo in Myeloma Clinical Trial page.